"Serious limitations" identified in high BP management in Pakistan

Author：

ISSN： 1173-8324

Source： Inpharma, Vol.1, Iss.1486, 2005-01, pp. : 6-6

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

A meta-analysis has identified a significantly increased risk of serious adverse events and treatment discontinuation in patients receiving telaprevir

Reactions Weekly, Vol. 1, Iss. 1419, 2012-01 ,pp. : 3-3

Adis International

Access to resources Recommend Favorite

Amlodipine/valsartan forges ahead in the fight against high BP

Inpharma, Vol. 1, Iss. 1541, 2006-01 ,pp. : 5-6

Adis International

Access to resources Recommend Favorite

Quinupristin/Dalfopristin: A Review of its Use in the Management of Serious Gram-Positive Infections

By Lamb H.M. Figgitt D.P. Faulds D.

Drugs, Vol. 58, Iss. 6, 1999-12 ,pp. : 1061-1097

Adis International

Access to resources Recommend Favorite

Linezolid: A Review of its Use in the Management of Serious Gram-Positive Infections

By Perry C.M. Jarvis B.

Drugs, Vol. 61, Iss. 4, 2001-01 ,pp. : 525-551

Adis International

Access to resources Recommend Favorite

The incidence of osteoporosis is high in Northern Pakistan, but can be managed at minimal cost

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 563, 2008-01 ,pp. : 8-8

Adis International

Access to resources Recommend Favorite